Dowsett M - Search Results

1

ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer.

Pinhel I, Hills M, Drury S, Salter J, Sumo G, A'Hern R, Bliss JM, Sestak I, Cuzick J, Barrett-Lee P, Harris A, Dowsett M; NCRI Adjuvant Breast Cancer Trial Management Group. Pinhel I, et al. Among authors: dowsett m. Breast Cancer Res. 2012 Mar 14;14(2):R46. doi: 10.1186/bcr3145. Breast Cancer Res. 2012. PMID: 22417870 Free PMC article. Clinical Trial.

2

New hurdles for translational research.

Dowsett M. Dowsett M. Breast Cancer Res. 2000;2(4):241-3. doi: 10.1186/bcr62. Epub 2000 May 24. Breast Cancer Res. 2000. PMID: 11250714 Free PMC article.

3

Effects of the aromatase inhibitor letrozole on normal breast epithelial cell proliferation and metabolic indices in postmenopausal women: a pilot study for breast cancer prevention.

Harper-Wynne C, Ross G, Sacks N, Salter J, Nasiri N, Iqbal J, A'Hern R, Dowsett M. Harper-Wynne C, et al. Among authors: dowsett m. Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):614-21. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12101108 Clinical Trial.

4

Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivation.

Chan CM, Martin LA, Johnston SR, Ali S, Dowsett M. Chan CM, et al. Among authors: dowsett m. J Steroid Biochem Mol Biol. 2002 Aug;81(4-5):333-41. doi: 10.1016/s0960-0760(02)00074-2. J Steroid Biochem Mol Biol. 2002. PMID: 12361723

5

Integration of signal transduction inhibitors with endocrine therapy: an approach to overcoming hormone resistance in breast cancer.

Johnston SR, Head J, Pancholi S, Detre S, Martin LA, Smith IE, Dowsett M. Johnston SR, et al. Among authors: dowsett m. Clin Cancer Res. 2003 Jan;9(1 Pt 2):524S-32S. Clin Cancer Res. 2003. PMID: 12538510 Review.

6

Human epidermal growth factor receptor-2 and hormonal therapies: clinical implications.

Ring A, Dowsett M. Ring A, et al. Among authors: dowsett m. Clin Breast Cancer. 2003 Apr;4 Suppl 1:S34-41. doi: 10.3816/cbc.2003.s.013. Clin Breast Cancer. 2003. PMID: 12756077 Review.

7

Phase II study of the efficacy and tolerability of two dosing regimens of the farnesyl transferase inhibitor, R115777, in advanced breast cancer.

Johnston SR, Hickish T, Ellis P, Houston S, Kelland L, Dowsett M, Salter J, Michiels B, Perez-Ruixo JJ, Palmer P, Howes A. Johnston SR, et al. Among authors: dowsett m. J Clin Oncol. 2003 Jul 1;21(13):2492-9. doi: 10.1200/JCO.2003.10.064. J Clin Oncol. 2003. PMID: 12829668 Clinical Trial.

8

Role of biologic markers in patient selection and application to disease prevention.

Dowsett M, Ellis MJ. Dowsett M, et al. Am J Clin Oncol. 2003 Aug;26(4):S34-9. doi: 10.1097/00000421-200308001-00006. Am J Clin Oncol. 2003. PMID: 12902875

9

Endocrinology and hormone therapy in breast cancer: aromatase inhibitors versus antioestrogens.

Howell A, Dowsett M. Howell A, et al. Among authors: dowsett m. Breast Cancer Res. 2004;6(6):269-74. doi: 10.1186/bcr945. Epub 2004 Oct 6. Breast Cancer Res. 2004. PMID: 15535858 Free PMC article. Review.

10

Translational research and the changing face of breast cancer.

Dowsett M. Dowsett M. Breast Cancer Res Treat. 2004;87 Suppl 1:S1-2. doi: 10.1007/s10549-004-1576-5. Breast Cancer Res Treat. 2004. PMID: 15597214

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

739 results

Search Page

Filters